Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome
We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Biogen Inc. stands sixth on our list among the most undervalued stocks. Biogen Inc. (NASDAQ:BIIB) is a global biotechnology leader known for its treatments in multiple sclerosis (MS), …